IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q3 FY20 results · Oct–Dec 2019
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹511.25 crore (up 6.9% from Q3 FY19) and net profit of ₹98.01 crore (up 19.2% from Q3 FY19) for Q3 FY20 (Oct–Dec 2019), on a standalone basis.
| Item | Q3 FY20 | Q3 FY19 | YoY | Q2 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 511.25 | 478.29 | +6.9% | 448.96 | +13.9% |
| Other income | 3.96 | 0.85 | +365.9% | 3.39 | +16.8% |
| Total income | 515.21 | 479.14 | +7.5% | 452.35 | +13.9% |
| Profit before tax | 150.76 | 115.13 | +30.9% | 121.38 | +24.2% |
| Net profit for the period | 98.01 | 82.24 | +19.2% | 87.70 | +11.8% |
| EPS, basic (₹) | 17.22 | 14.63 | +17.7% | 15.42 | +11.7% |
| Net margin (%) | 19.2 | 17.2 | 19.5 |
Standalone
- Filed with BSE
- 11 Feb 2020, 14:39 IST
- Board meeting
- 10 Feb 2020
- Period
- 01 Oct 2019 to 31 Dec 2019
- Review status
- Audited
- Source
- XBRL filing on BSE